-
Human subjects research organizations need a thorough, fair, and effective way of handling complaints and concerns about research trial ethical and regulatory violations.
-
-
[This special issue of Same-Day Surgery focuses on the most significant infection control issues facing ambulatory surgery managers. In our cover package, we tell you about a recent pilot study that found infection control practices were lacking, and we share lessons learned. Also in this issue, we tell you about a new guideline from the Society for Healthcare Epidemiology of America (SHEA) regarding the management of providers who are infected with hepatitis B, hepatitis C, and HIV. We let you know how this guideline will impact your day-to-day practice.]
-
[Editor's note: This is the first part of a two-part series on a new guideline from the Society for Healthcare Epidemiology of America (SHEA) regarding health care providers who are infected with hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV). In this issue, we give you an overview of what the guideline did and did not include, which procedures are at greatest risk of transmission to patients, and the recommendations for infected staff. In next month's issue, we discuss how to decide which workers to test and further explain the new guideline.]
-
-
I have met with some interesting people over the past 30 days "interesting" is not always a good thing and the future of health care is starting to gel with some.
-
Risk managers expect accreditation records to be confidential, and The Joint Commission (TJC) urges providers to fully disclose information about adverse events and deficiencies as part of the quality improvement process. But some risk managers are learning that those records are not as private as often thought.
-
If providers worry that The Joint Commission (TJC) will release their accreditation records to prosecutors, they may become reluctant to share sensitive information with the accrediting body, cautions Vickie Patterson, an associate director in the Atlanta office of Protiviti, a risk consulting firm.
-
The federal Food and Drug Administration (FDA) in Washington, DC, announced recently that it will strengthen its oversight of three of the most potent forms of medical radiation, including computed tomography (CT) scans.
-
Reprocessing of single-use devices is becoming increasingly popular among U.S. health care organizations, which are drawn to the potential cost savings and, more recently, the effort to go green by reducing waste. But do those benefits bring liability risks?
